Anderson, RA, Polansky MM, Bryden NA. Strenuous running: acute effects on chromium, copper, zinc, and selected clinical variables in urine and serum of male runners. Biology Trace elements res. 1984; 6: 327-336

Anderson, RA, Polansky MM, Bryden NA. Effects of carbohydrate loading and underwater exercise on circulating cortisol, insulin and urinary losses of chromium and zinc. Eur Journal of Applied Physiology, 1991;3:289-293.

Williams, M, 1995, Chromium, Nutrition for Fitness and Sport, Brown and Benchmark publications.

Reading SA. Chromium picolinate. J Fla Med Assoc. 1996 Jan;83(1):29-31

Walker LS, Bemben MG, Bemben DA, Knehans AW. Chromium picolinate effects on body composition and muscular performance in wrestlers. Med Sci Sports Ex. 1998 Dec;30(12):1730-7.

Xiu; Journal of China Sports Medicine (Vol 15, No.4. 1996)

Saratikov AS., Salnik BU., Revina TA 1968. Biochemical Characteristics of the Stimulative action of Rodosine during prescribed muscular workloads. Proceedings of Siberian Department of Academy of sciences of the USSR. Biological Sciences, 5: 108-115.

Xu J; Xie J; Feng P; Su Z; Oxygen transfer characteristics in the compact callus aggregates of Rhodiola. Chinise Journal of Biotechnology; 1998; 14(2): 99-107.

Wang Liang, Progress of research on the pharmacology of rhodiola, Li Shizhen Medicine and Materia Medica Research 1999; 10(4): 295-296.

 Burke, Edmund R. Herbs Enhance Lactate Metabolism. Nutrition Science News, V.3; N.9 P. 458 (1998)

Weber C, Jakobsen TS, Mortensen SA, et al. Antioxidative effect of dietary coenzyme Q10 in human blood plasma. Internat J Vit Nutr Res 1994;64:311-15.

Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure. Drug Exptl Clin Res 1985;11:581-93.

Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 in patients with congestive heart failure: a long-term multicenter randomized study. Clin Invest 1993;71:S134-6.

Kamikawa T, Kobayashi A, Yamashita T, et al. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol 1985;56:247.

Mortensen SA. Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone). Clin Invest 1993;71:s116–23 [review].

Jolliet P, et al. Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequences. Int J Clin Pharmacol Ther 1998 Sep;36(9):506-9.

Matthews RT, et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A 1998 Jul 21;95(15):8892-7.

Chopra RK, Goldman R, Sinatra ST, Bhagavan HN. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int J Vitam Nutr Res 1998;68(2):109-13.

International J Vit Nutr Research, 1992;62(2):160-4.

Biochem Biophy Res Comm, 1991;176:349-55.

Biomedical and Clinical Aspects of Coenzyme Q, 1991, vol. 6.

Molec Aspects Med, 1997;18(suppl):283S-290S.

Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J. 1969;100:682.

Combs GF. Selenium and cancer. In: Wang Z, ed. Biochemistry and Molecular Biology of Selenium. Beijing, China: Chinese Adademy of Science. 1995.

Clark LC, Combs GF, Turnbull BW, Slate EH, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA. 1996; 276(24):1957-1963.

Knekt P, Marniemi J, Teppo L, Heliovaara M, Aromaa A. Is low selenium status a risk factor for lung cancer? Am J of Epidemiology. 1998; 148: 975-982.

Giovannucci E. Selenium and risk of prostate cancer. Lancet. 1998; 352(9130): 755-756.

Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998; 90(16): 1219-1224.

Clark LC, Dalkin B, Krongrad A, Combs GF Jr, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol. 1998; 81(5):730-4.

American Journal of Epidemiology. 1999;150:367-374

Kiremidjian-Schumacher L, Stotsky G. Selenium and immune responses. Environmental Res. 1987; 42:277-303.

Vinson JA, et al. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking. FEBS Lett. 1998;433(1-2):44-6.

Dulloo AG, et al. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord 2000 Feb;24(2):252-8

Dulloo AG, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999 Dec;70(6):1040-5.

Gao YT, et al. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Can Inst. 1994; 54: 3428-2435.

Yang CS, Wang ZY. Tea and cancer. J Natl Can Inst. 1993; 85(13):1038-49.

Murray M. Green tea. The Am J of Natural Med. 1997; 4(5):18-19.

Elders PJM, et al. Long-term effects of calcium supplementation on bone loss in perimenopausal women. J Bone Min Res. 1994; 9:963-70.

Devine A, et al. A 4-year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women. Osteoporosis Int. 1997; 7:23-28.

Murray MT. Osteoporosis Prevention and Treatment--Beyond Calcium. Natural Medicine Journal. 1999; 2: 3-13.

Mazaregos-Ramos E, et al. Consumption of soft drinks with phosphoric acid as a risk factor for the development of hypocalcemia in children: A case-control study. J Pediatr. 1995; 126: 940-2.

Pizzorno J. Total Wellness. Rocklin, CA: Prima Publishing, 1998, p.62.

Burton GW, et al. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr. 1998; 67:669-684.

Murray MT. Encyclopedia of Nutritional Supplements. CA: Prima Publishing, 1996, p.53.

Princen HMG, et al. Supplementation with low doses of Vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler, Thromb, and Vasc Biol. 1995; 15: 325-333.

Devaraj S, Jialal I. Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler, Thromb, and Vasc Biol. 1999; 19(4):1125-33.

Belcher JD, Balla J, Balla G, et al. Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb. 1993; 13: 1779-1789.

Leppälä JM, Virtamo J, Fogelholm R, et al. Vitamin E and beta carotene supplementation in high risk for stroke: A subgroup analysis of the alpha-tocopherol, beta carotene cancer prevention study. Archives of Neurology. 2000; 57:1503-1509.

Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary heart disease in women. New Engl J of Med. 1993; 328:1444-1449.

Stephans NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet. 1996; 347(9004): 1849-54.

Davey PJ, et al. Cost-effectiveness of vitasmin E therapy is the treatment of patients with angiographically proven narrwoinhg (CHAOS trial). Am J Cardiol. 1998; 82:414-7.

Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA. 1997; 277: 1380-6.

Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J of Med. 1993; 328: 1450-1456.

Tutuncu NB, Bayraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care. 1998; 21(11):1915-1918.

Diabetes Care. 1999; 22:1245-1251.

 American Journal of Epidemiology. 1999; 150: 37-44.

 American Journal of Epidemiology. 1999; 150:290-300.